Effects of treadmill exercise on skeletal muscle mTOR signaling pathway in high-fat diet-induced obese mice

Journal of Physical Therapy Science

Volumn 28, Issue 4, 2016, Pages 1260-1265

  Woo, Jin Hee ^a   Shin, Ki Ok ^a   Lee, Yul Hyo ^a   Jang, Ki Soeng ^a   Bae, Ju Yong ^a   Roh, Hee Tae ^a  

^a Dong A University   (South Korea)

Author keywords

Exercise; High fat diet; MTOR

Indexed keywords

EID: 84964758636     PISSN: 09155287     EISSN: None     Source Type: Journal    
DOI: 10.1589/jpts.28.1260     Document Type: Article

References (39)

1. Lee SS, Yoo JH, Kang S, et al.: The effects of 12 weeks regular aerobic exercise on brain-derived neurotrophic factor and inflammatory factors in juvenile obesity and type 2 diabetes mellitus. J Phys Ther Sci, 2014, 26: 1199–1204.[Medline] [CrossRef]
2. Cho JH, Namgung JS, Lee J, et al.: Analysis of biochemical markers related to fatty liver patients. J Phys Ther Sci, 2014, 26: 1865–1868.[Medline] [CrossRef]
3. Ko SS, Chung JS, So WY: Correlation between waist and mid-thigh circumference and cardiovascular fitness in Korean college students: a case study. J Phys Ther Sci, 2015, 27: 3019–3021.[Medline] [CrossRef]
4. Koca I, Boyaci A, Tutoglu A, et al.: The relationship between quadriceps thickness, radiological staging, and clinical parameters in knee osteoarthritis. J Phys Ther Sci, 2014, 26: 931–936.[Medline] [CrossRef]
5. Yagura C, Kihara I, Hashimot M, et al.: Relationship between large and small arterial compliance and regional body composition in middle-aged and elderly adults. J Phys Ther Sci, 2009, 21: 337–342. [CrossRef]
6. Hara K, Maruki Y, Long X, et al.: Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell, 2002, 110: 177–189.[Medline] [CrossRef]
7. Laplante M, Sabatini DM: mTOR signaling in growth control and disease. Cell, 2012, 149: 274–293.[Medline] [Cross- Ref]
8. Rivas DA, Lessard SJ, Coffey VG: mTOR function in skeletal muscle: a focal point for overnutrition and exercise. Appl Physiol Nutr Metab, 2009, 34: 807–816.[Medline] [CrossRef]
9. Yang X, Yang C, Farberman A, et al.: The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth. J Anim Sci, 2008, 86: E36–E50.[Medline] [CrossRef]
10. Rasmussen BB, Richter EA: The balancing act between the cellular processes of protein synthesis and breakdown: exercise as a model to understand the molecular mechanisms regulating muscle mass. J Appl Physiol 1985, 2009, 106: 1365–1366.[Medline] [CrossRef]
11. Kim MY, Lee JU, Kim JH, et al.: Decrease of PKB/Akt phosphorylation is partially mediated by SAPK/JNK activation in serum-free L6 myoblasts starved with low glucose. J Phys Ther Sci, 2014, 26: 1757–1760.[Medline] [CrossRef]
12. Yang Z, Ming XF: mTOR signalling: the molecular interface connecting metabolic stress, aging and cardiovascular diseases. Obes Rev, 2012, 13: 58–68.[Medline] [CrossRef]
13. Wang X, Hu Z, Hu J, et al.: Insulin resistance accelerates muscle protein degradation: activation of the ubiquitinproteasome pathway by defects in muscle cell signaling. Endocrinology, 2006, 147: 4160–4168.[Medline] [CrossRef]
14. Rommel C, Bodine SC, Clarke BA, et al.: Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/ mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol, 2001, 3: 1009–1013.[Medline] [CrossRef]
15. Dreyer HC, Fujita S, Cadenas JG, et al.: Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle. J Physiol, 2006, 576: 613–624.[Medline] [CrossRef]
16. Mascher H, Tannerstedt J, Brink-Elfegoun T, et al.: Repeated resistance exercise training induces different changes in mRNA expression of MAFbx and MuRF-1 in human skeletal muscle. Am J Physiol Endocrinol Metab, 2008, 294: E43–E51.[Medline] [CrossRef]
17. Atherton PJ, Babraj J, Smith K, et al.: Selective activation of AMPK-PGC-1alpha or PKB-TSC2-mTOR signaling can explain specific adaptive responses to endurance or resistance training-like electrical muscle stimulation. FASEB J, 2005, 19: 786–788.[Medline]
18. Williamson DL, Kubica N, Kimball SR, et al.: Exercise-induced alterations in extracellular signal-regulated kinase 1/2 and mammalian target of rapamycin (mTOR) signalling to regulatory mechanisms of mRNA translation in mouse muscle. J Physiol, 2006, 573: 497–510.[Medline] [CrossRef]
19. Kemp JG, Blazev R, Stephenson DG, et al.: Morphological and biochemical alterations of skeletal muscles from the genetically obese (ob/ob) mouse. Int J Obes, 2009, 33: 831–841.[Medline] [CrossRef]
20. Russell AP: Molecular regulation of skeletal muscle mass. Clin Exp Pharmacol Physiol, 2010, 37: 378–384.[Medline] [CrossRef]
21. Deldicque L, Louis M, Theisen D, et al.: Increased IGF mRNA in human skeletal muscle after creatine supplementation. Med Sci Sports Exerc, 2005, 37: 731–736.[Medline] [CrossRef]
22. Richard-Bulteau H, Serrurier B, Crassous B, et al.: Recovery of skeletal muscle mass after extensive injury: positive effects of increased contractile activity. Am J Physiol Cell Physiol, 2008, 294: C467–C476.[Medline] [CrossRef]
23. Li Z, Dungan CM, Carrier B, et al.: Alpha-lipoic acid supplementation reduces mTORC1 signaling in skeletal muscle from high fat fed, obese Zucker rats. Lipids, 2014, 49: 1193–1201.[Medline] [CrossRef]
24. Møller AB, Vendelbo MH, Rahbek SK, et al.: Resistance exercise, but not endurance exercise, induces IKKβ phosphorylation in human skeletal muscle of training-accustomed individuals. Pflugers Arch, 2013, 465: 1785–1795.[Medline] [CrossRef]
25. Goodman CA, Frey JW, Mabrey DM, et al.: The role of skeletal muscle mTOR in the regulation of mechanical loadinduced growth. J Physiol, 2011, 589: 5485–5501.[Medline] [CrossRef]
26. Bentzinger CF, Romanino K, Cloëtta D, et al.: Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab, 2008, 8: 411–424.[Medline] [CrossRef]
27. Khamzina L, Veilleux A, Bergeron S, et al.: Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology, 2005, 146: 1473–1481.[Medline] [CrossRef]
28. Takano A, Usui I, Haruta T, et al.: Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin. Mol Cell Biol, 2001, 21: 5050–5062.[Medline] [CrossRef]
29. Williamson DL: Normalizing a hyperactive mTOR initiates muscle growth during obesity. Aging (Albany, NY Online), 2011, 3: 83–84.[Medline]
30. Dann SG, Selvaraj A, Thomas G: mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol Med, 2007, 13: 252–259.[Medline] [CrossRef]
31. Pagano AF, Py G, Bernardi H, et al.: Autophagy and protein turnover signaling in slow-twitch muscle during exercise. Med Sci Sports Exerc, 2014, 46: 1314–1325.[Medline] [CrossRef]
32. Liao B, Xu Y: Exercise improves skeletal muscle insulin resistance without reduced basal mTOR/S6K1 signaling in rats fed a high-fat diet. Eur J Appl Physiol, 2011, 111: 2743–2752.[Medline] [CrossRef]
33. Um SH, D’Alessio D, Thomas G: Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K 1. Cell Metab, 2006, 3: 393–402.[Medline] [CrossRef]
34. Sarbassov DD, Guertin DA, Ali SM, et al.: Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science, 2005, 307: 1098–1101.[Medline] [CrossRef]
35. Guertin DA, Stevens DM, Thoreen CC, et al.: Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K 1. Dev Cell, 2006, 11: 859–871.[Medline] [CrossRef]
36. Kumar A, Lawrence JC Jr, Jung DY, et al.: Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism. Diabetes, 2010, 59: 1397–1406.[Medline] [CrossRef]
37. Cleasby ME, Reinten TA, Cooney GJ, et al.: Functional studies of Akt isoform specificity in skeletal muscle in vivo; maintained insulin sensitivity despite reduced insulin receptor substrate-1 expression. Mol Endocrinol, 2007, 21: 215–228.[Medline] [CrossRef]
38. Izumiya Y, Hopkins T, Morris C, et al.: Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab, 2008, 7: 159–172.[Medline] [CrossRef]
39. Wu M, Falasca M, Blough ER: Akt/protein kinase B in skeletal muscle physiology and pathology. J Cell Physiol, 2011, 226: 29–36.[Medline] [CrossRef]